{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T10:30:29Z","timestamp":1793183429131,"version":"4.5.0"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2018,4,10]],"date-time":"2018-04-10T00:00:00Z","timestamp":1523318400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Global Action Fund for Fungal Infections"},{"DOI":"10.13039\/100010643","name":"Cidara Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010643","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0193732","type":"journal-article","created":{"date-parts":[[2018,4,10]],"date-time":"2018-04-10T17:25:00Z","timestamp":1523381100000},"page":"e0193732","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":90,"title":["Twelve-month clinical outcomes of 206 patients with chronic pulmonary aspergillosis"],"prefix":"10.1371","volume":"13","author":[{"given":"Felix","family":"Bongomin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Kosmidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5626-2251","authenticated-orcid":true,"given":"David W.","family":"Denning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,4,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.1086\/376526","article-title":"Chronic Cavitary and Fibrosing Pulmonary and Pleural Aspergillosis: Case Series, Proposed Nomenclature Change, and Review","volume":"37","author":"DW Denning","year":"2003","journal-title":"Clin Infect Dis"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1183\/13993003.00583-2015","article-title":"Chronic pulmonary aspergillosis: Rationale and clinical guidelines for diagnosis and management","volume":"47","author":"DW Denning","year":"2016","journal-title":"Eur Respir J"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/thoraxjnl-2014-206291","article-title":"The clinical spectrum of pulmonary aspergillosis","volume":"70","author":"C Kosmidis","year":"2015","journal-title":"Thorax"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.rmed.2012.01.014","article-title":"Clinical characteristics and prognosis of chronic pulmonary aspergillosis","volume":"106","author":"H Ohba","year":"2012","journal-title":"Respir Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12890-016-0276-3","article-title":"Aspergillus nodules; another presentation of Chronic Pulmonary Aspergillosis","volume":"16","author":"EG Muldoon","year":"2016","journal-title":"BMC Pulm Med. BMC Pulmonary Medicine"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1378\/chest.92.3.505","article-title":"Aspergilloma in sarcoid and tuberculosis","volume":"92","author":"JR Tomlinson","year":"1987","journal-title":"Chest"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3109\/13693786.2013.806826","article-title":"Clinical characteristics and treatment outcomes of chronic pulmonary aspergillosis","volume":"51","author":"BW Jhun","year":"2013","journal-title":"Med Mycol"},{"key":"ref8","first-page":"621","article-title":"Pulmonary aspergilloma: analysis of cavitating invasive pulmonary aspergillosis in immunocompromised patients","volume":"53","author":"J Jewkes","year":"1983","journal-title":"Ann Thorac Surg"},{"key":"ref9","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01062-2016","article-title":"Predictors of mortality in chronic pulmonary aspergillosis","volume":"49","author":"D Lowes","year":"2017","journal-title":"Eur Respir J"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1086\/657306","article-title":"Efficacy and Safety of Posaconazole for Chronic Pulmonary Aspergillosis","volume":"51","author":"TW Felton","year":"2010","journal-title":"Clin Infect Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/myc.12075","article-title":"Itraconazole in chronic cavitary pulmonary aspergillosis: A randomised controlled trial and systematic review of literature","volume":"56","author":"R Agarwal","year":"2013","journal-title":"Mycoses"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America","volume":"63","author":"TF Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s10156-012-0414-7","article-title":"Efficacy and safety of short- and long-term treatment of itraconazole on chronic necrotizing pulmonary aspergillosis in multicenter study","volume":"18","author":"K Yoshida","year":"2012","journal-title":"J Infect Chemother. Elsevier"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/13693780701278386","article-title":"Clinical efficacy of micafungin for chronic pulmonary aspergillosis","volume":"45","author":"K Izumikawa","year":"2007","journal-title":"Med Mycol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.chest.2016.02.640","article-title":"CT Imaging Assessment of Response to Treatment in Chronic Pulmonary Aspergillosis","volume":"150","author":"C Godet","year":"2016","journal-title":"Chest"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/cid\/cit411","article-title":"Long-term antifungal treatment improves health status in patients with chronic pulmonary aspergillosis: A longitudinal analysis","volume":"57","author":"K Al-Shair","year":"2013","journal-title":"Clin Infect Dis"},{"key":"ref17","first-page":"1","article-title":"St George \u2018 S Respiratory Questionnaire for Copd Patients (Sgrq-C)","volume":"44","author":"PW Jones","year":"2008","journal-title":"Structure"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1164\/ajrccm.156.2.9607083","article-title":"Validation of the St. George\u2019s respiratory questionnaire in bronchiectasis","volume":"156","author":"CB Wilson","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1378\/chest.12-0014","article-title":"Validity and reliability of the St. George\u2019s respiratory questionnaire in assessing health status in patients with chronic pulmonary aspergillosis","volume":"144","author":"K Al-Shair","year":"2013","journal-title":"Chest"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1183\/09031936.02.00063702","article-title":"Interpreting thresholds for a clinically significant change in health status in asthma and COPD","volume":"19","author":"PW Jones","year":"2002","journal-title":"Eur Respir J"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1183\/09031936.94.07010055","article-title":"Quality of life, symptoms and pulmonary function in asthma: long-term treatment with nedocromil sodium examined in a controlled multicentre trial. Nedocromil Sodium Quality of Life Study Group","volume":"7","author":"PW Jones","year":"1994","journal-title":"Eur Respir J"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1164\/ajrccm.155.4.9105068","article-title":"Quality of life changes in COPD patients treated with salmeterol","volume":"155","author":"PW Jones","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/occmed\/kqm162","article-title":"The MRC breathlessness scale","volume":"58","author":"C Stenton","year":"2008","journal-title":"Occup Med (Lond)"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jinf.2015.11.003","article-title":"Comparison of six Aspergillus-specific IgG assays for the diagnosis of chronic pulmonary aspergillosis (CPA)","volume":"72","author":"ID Page","year":"2016","journal-title":"J Infect"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1136\/thx.46.11.839","article-title":"Treatment of pulmonary aspergilloma with itraconazole","volume":"46","author":"JH Campbell","year":"1991","journal-title":"Thorax"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2169\/internalmedicine.39.209","article-title":"Clinical evaluation of 61 patients with pulmonary aspergilloma","volume":"39","author":"S Kawamura","year":"2000","journal-title":"Intern Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1016\/j.jinf.2005.08.022","article-title":"The efficacy and tolerability of voriconazole in the treatment of chronic cavitary pulmonary aspergillosis","volume":"52","author":"LR Jain","year":"2006","journal-title":"J Infect"},{"key":"ref28","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2005.11.028","article-title":"Voriconazole Treatment for Subacute Invasive and Chronic Pulmonary Aspergillosis","volume":"119","author":"H Sambatakou","year":"2006","journal-title":"Am J Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1007\/s10096-012-1690-y","article-title":"Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial","volume":"31","author":"J Cadranel","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1378\/chest.06-2441","article-title":"Treatment of chronic pulmonary aspergillosis by voriconazole in nonimmunocompromised patients","volume":"131","author":"J Camuset","year":"2007","journal-title":"Chest"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/cid\/cir179","article-title":"High-frequency triazole resistance found in nonculturable aspergillus fumigatus from lungs of patients with chronic fungal disease","volume":"52","author":"DW Denning","year":"2011","journal-title":"Clin Infect Dis"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3201\/eid1507.090043","article-title":"Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure","volume":"15","author":"SJ Howard","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.1128\/AAC.00304-11","article-title":"Cryptic species and azole resistance in the Aspergillus niger complex","volume":"55","author":"SJ Howard","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1469-0691.2009.02911.x","article-title":"Azole resistance in allergic bronchopulmonary aspergillosis and Aspergillus bronchitis","volume":"16","author":"SJ Howard","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1128\/AAC.00517-11","article-title":"Interrogation of related clinical pan-azole-resistant Aspergillus fumigatus strains: G138C, Y431C, and G434C single nucleotide polymorphisms in cyp51A, upregulation of cyp51A, and integration and activation of transposon Atf1 in the cyp51A promoter","volume":"55","author":"AM Albarrag","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/jac\/dkt508","article-title":"Therapeutic drug monitoring (TDM) of antifungal agents: Guidelines from the british society for medical mycology","volume":"69","author":"HR Ashbee","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"ref37","first-page":"1","article-title":"Impact of liposomal amphotericin B therapy on chronic pulmonary aspergillosis","author":"PJ Newton","year":"2016","journal-title":"J Infect. Elsevier Ltd"},{"key":"ref38","first-page":"688","article-title":"Clinical efficacy and safety of micafungin in Japanese patients with chronic pulmonary aspergillosis: a prospective observational study","volume":"49","author":"S Kohno","year":"2011","journal-title":"Med Mycol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1080\/00365540410020406","article-title":"A multicenter, open-label clinical study of micafungin (FK463) in the treatment of deep-seated mycosis in Japan","volume":"36","author":"S Kohno","year":"2004","journal-title":"Scand J Infect Dis"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10096-012-1754-z","article-title":"A double-blind comparative study of the safety and efficacy of caspofungin versus micafungin in the treatment of candidiasis and aspergillosis","volume":"32","author":"S Kohno","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0193732","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T20:27:39Z","timestamp":1588969659000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0193732"}},"subtitle":[],"editor":[{"given":"Sanjay Haresh","family":"Chotirmall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,4,10]]},"references-count":40,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,4,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0193732","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,10]]}}}